This new volume delves into the emerging field of drug repurposing, which involves identifying new pharmacological indications for existing drugs and applying them in the treatment of diseases beyond their original intended therapeutic use. The book highlights recent advances in drug repurposing and computational approaches for discovering and developing drugs to address challenging and life-threatening diseases.

Key Features:

Explores sophisticated tools and techniques used in drug repurposing and computational drug discovery.
Presents contributions from a global team of experts, including academicians, scientists, and researchers.
Covers computational techniques, tools, and databases employed in drug repurposing for various diseases.
Focuses on microbial infections (bacterial, fungal, viral, COVID-19), parasitic diseases, neglected tropical diseases (NTDs), cancer, inflammatory diseases, cardiovascular disorders, diabetes, aging, and neurological (CNS) disorders.
Examines challenges and regulatory issues in drug repurposing and computational drug discovery programs.
This comprehensive resource provides valuable insights into the innovative approaches and strategies shaping drug repurposing and computational drug discovery, offering perspectives on the future directions of this evolving field.